Allie Strickler

Using Androgen Receptor Blockers to Treat Triple-Negative Breast Cancer

March 27, 2017

Article

Michael F. Press, M.D., Ph.D., shed light on the role of the receptor in breast cancer in a presentation during the 2017 Miami Breast Cancer Conference.

Some Breast Cancer Patients May Be Misclassified, Expert Explains

March 14, 2017

Article

New guidelines may result in a small percentage of patients with breast cancer being misclassified and not receiving proper treatment, Michael F. Press, M.D., Ph.D., says.

Weight Loss Lowers Endometrial Cancer Risk

February 11, 2017

Article

Lowering weight may lead to lowering the risk for developing endometrial cancer, according to recent findings.

The Addition of Hormone Therapy Improves Survival in Recurrent Prostate Cancer

February 09, 2017

Article

Adding hormone therapy to radiation therapy after surgery showed significant survival improvements in a recent study involving men with recurrent prostate cancer.

Study Examines Racial Disparities in Cervical Cancer Death Rates

February 08, 2017

Article

A racial disparity exists among patients who die from cervical cancer, according to the results from a recent study.

Diagnostic Laparoscopies Can Prevent Future Surgeries in Ovarian Cancer

February 01, 2017

Article

Diagnostic laparoscopy can play a role in predicting surgery outcomes for patients with ovarian cancer.

New Marker Identifies Men With Prostate Cancer at Risk for Death

January 30, 2017

Article

Findings from a recent study lay out the groundwork to help identify men who are at higher risk from dying of prostate cancer.

As HPV-Related Cancer Rates Rise, Vaccination Numbers Remain Low

January 27, 2017

Article

From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.

Researchers Found a New Cervical Cancer Subtype

January 24, 2017

Article

A new subtype of cervical cancer was found that does not express the HPV oncogene.

Expert Discusses Keytruda's Future in Lung Cancer

January 20, 2017

Article

Roy Herbst, M.D., Ph.D., spoke with CURE about the future of Keytruda, and immunotherapy in general, to treat lung cancer.

Fewer Men Are Being Treated for Prostate Cancer After Screening Recommendations Changed

January 19, 2017

Article

A recent study found that there has been a sharp decrease in the percentage of men who are being treated for prostate cancer.

Wait-and-Watch May Be a Strategy for Patients With Rectal Cancer

January 18, 2017

Article

The results of a recent study showed that a wait-and-watch approach may be appropriate for patients with rectal cancer.

Predicting HPV+ Oropharyngeal Cancer Recurrence With Novel Biomarker

January 18, 2017

Article

There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.

Vaccine Shows Benefit in Early-Stage Breast Cancer

January 13, 2017

Article

Brian J. Czerniecki, M.D., Ph.D., discusses a promising vaccine for certain patients with breast cancer.

Expert Discusses Local Control in Ewing Sarcoma

January 10, 2017

Article

Dimosthenis Andreou, M.D., discussed the Euro-EWING99 trial with CURE.

In Ovarian Cancer Advancements, Finding New Biomarkers Is Key

January 05, 2017

Article

Finding new biomarkers should be the top priority in ovarian cancer research, Maurie Markman, M.D., says.

NSAID Use May Affect Endometrial Cancer Outcomes, Study Finds

January 04, 2017

Article

Over-the-counter pain management drugs may negatively affect the outcomes of patients with endometrial cancer, a recent study found.

Early Surgery May Increase Mortality Rates in Endometrial Cancer

January 03, 2017

Article

Expedited surgery for patients who are recently diagnosed with endometrial cancer may actually lead to increased mortality, according to a recent study.

Treatment Method Shows Local Control of Cervical Cancer

December 29, 2016

Article

Computed-tomography (CT)-planned high-dose-rate (HDR) intracavitary brachytherapy (BT) showed excellent local control for patients with stage 1 or 2 cervical cancer, according to a recent study.

Bladder Cancer Treatments Continue to Evolve

December 09, 2016

Article

The treatment landscape of bladder cancer drastically changed this spring with the approval of an immunotherapy agent, and will continue to shift in the months and years to come.

Immunotherapy Agent Improved Quality of Life in Lung Cancer Study

December 08, 2016

Article

Keytruda improved quality of life for patients with lung cancer in a recent trial.

Treatment Continues to Advance in Ovarian Cancer and Other Gynecologic Malignancies

December 01, 2016

Article

With the addition of PARP inhibitors, as well as new agents on the horizon, the treatment landscape of gynecologic cancers is progressing.

Examining the Future of Immunotherapy in Head and Neck Cancer

November 18, 2016

Article

Everett Vokes, M.D. discusses what the future of immunotherapy might mean for patients with head and neck cancer.

Immunotherapy Agent Shows Promise in Advanced Bladder Cancer

November 02, 2016

Article

Opdivo had positive results in patients with advanced bladder cancer according to findings from the CheckMate-275 trial.

Regular Cervical Cancer Screening Reduces Mortality by 83 Percent

September 30, 2016

Article

A recent study found a correlation between frequent cervical cancer screenings and decreased mortality.

Better Survival With Vaginal Brachytherapy in Endometrial Cancer

September 20, 2016

Article

Women with stage 1 endometrioid adenocarcinoma of the uterus showed improved survival with vaginal brachytherapy (VB), according to a large database analysis published in the journal Cancer.